Published in Psychol Med on June 03, 2009
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) | NCT00021528
Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes | NCT03580967
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A (2011) 2.37
Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain (2011) 1.88
The effects of depression and smoking on pain severity and opioid use in patients with chronic pain. Pain (2010) 1.19
Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary. Drugs Context (2013) 0.87
Efficacy of duloxetine on painful physical symptoms in major depressive disorder for patients with clinically significant painful physical symptoms at baseline: a meta-analysis of 11 double-blind, placebo-controlled clinical trials. Prim Care Companion CNS Disord (2011) 0.85
General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci (2011) 0.82
Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a cross-sectional study. BMC Psychiatry (2011) 0.82
Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database. Clinicoecon Outcomes Res (2013) 0.80
The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder. J Headache Pain (2014) 0.79
Plant Natural Product Puerarin Ameliorates Depressive Behaviors and Chronic Pain in Mice with Spared Nerve Injury (SNI). Mol Neurobiol (2016) 0.77
Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study. Neuropsychiatr Dis Treat (2015) 0.77
Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management. CNS Drugs (2016) 0.77
Attributes of response in depressed patients switched to treatment with duloxetine. Int J Clin Pract (2010) 0.77
Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study. Neurol Ther (2013) 0.76
Depression treatment with duloxetine and reduction of inability to work. Depress Res Treat (2012) 0.76
Longitudinal changes in somatic symptoms and family disagreements among depression and community groups: a 23-year study. BMC Psychiatry (2015) 0.75
Effect of obstructive sleep apnea on response to cognitive behavior therapy for depression after an acute myocardial infarction. J Psychosom Res (2012) 0.75
Do Somatic Symptoms Predict the Severity of Depression? A Validation Study of the Korean Version of the Depression and Somatic Symptoms Scale. J Korean Med Sci (2016) 0.75
Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine. Neuropsychiatr Dis Treat (2017) 0.75
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry (1991) 8.37
The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med (1996) 7.70
Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv (2001) 4.93
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48
The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry (1997) 3.71
Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol (1996) 3.28
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry (1998) 3.27
Flexible treatment strategies in chronic disease: clinical and research implications. Biol Psychiatry (2000) 3.21
A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clin Pharmacol Ther (2010) 2.74
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA (1994) 2.74
Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc (2001) 2.73
The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. Psychiatr Serv (1999) 2.68
Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med (1997) 2.62
Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry (2000) 2.52
Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol (2001) 2.49
Redefining the role of psychiatry in medicine. Am J Psychiatry (1996) 2.45
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry (1997) 2.35
Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry (1998) 2.23
Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry (1999) 2.23
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT (2001) 2.21
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry (1998) 2.13
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry (1998) 2.12
The suboccipital cavernous sinus. J Neurosurg (1997) 2.06
Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry (2001) 1.93
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med (2009) 1.91
Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry (2001) 1.88
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry (1999) 1.84
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychol Med (2011) 1.83
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med (2000) 1.82
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry (1995) 1.73
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry (1996) 1.71
Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med (2010) 1.71
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatr Scand (2009) 1.67
Workplace performance effects from chronic depression and its treatment. J Health Econ (1998) 1.66
Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina (1999) 1.63
Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry (2000) 1.61
Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry (2000) 1.60
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry (2006) 1.58
Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Can J Psychiatry (2000) 1.57
Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area. Gastroenterology (1989) 1.55
Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med (1999) 1.53
The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry (2001) 1.53
Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity. Crit Care Med (2001) 1.52
Development of a brief screening instrument: the HANDS. Psychother Psychosom (2000) 1.51
Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology (2001) 1.51
Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. J Pediatr (2001) 1.50
Gender differences in personality disorders. Am J Psychiatry (1995) 1.48
Well-being, appraisal, and coping in African-American and Caucasian dementia caregivers: findings from the REACH study. Aging Ment Health (2004) 1.47
No long-term benefit from hypothermia after severe traumatic brain injury with secondary insult in rats. Crit Care Med (2000) 1.46
Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol (1999) 1.45
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord (1999) 1.45
[Mechanical fragmentation and intrapulmonary fibrinolysis in the treatment of massive pulmonary embolism hemodynamic repercussions]. Arch Bronconeumol (2001) 1.44
Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. Arch Gen Psychiatry (1981) 1.41
Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry (1992) 1.41
Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med (1992) 1.41
Perceptual asymmetry, plasma cortisol, and response to treatment in depressed outpatients. Biol Psychiatry (1991) 1.40
Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol (1997) 1.40
A cross-sectional study of private psychiatric practices under a single-payer health care system. Can J Psychiatry (1997) 1.39
Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord (2000) 1.39
Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Res (1994) 1.38
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry (2000) 1.37
A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol (2007) 1.36
Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma (1997) 1.36
Cerebrovascular response in infants and young children following severe traumatic brain injury: a preliminary report. Pediatr Neurosurg (1997) 1.33
SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet (2009) 1.32
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl Psychiatry (2011) 1.32
Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry (2000) 1.30
The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry (2009) 1.29
Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety (1998) 1.28
Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand (2005) 1.27
Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology (1999) 1.27
Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr (2008) 1.25
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24
MAOIs in the contemporary treatment of depression. Neuropsychopharmacology (1995) 1.23
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.22
Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest (1999) 1.21
Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med (2000) 1.21
Benzodiazepines as antidepressants: does GABA play a role in depression? Biol Psychiatry (1995) 1.21